Prolonged Release Tacrolimus Has Comparable Safety and Efficacy Profile as Standard Release Tacrolimus in Heart Transplant Recipients von Poglajen, G., Zemljič, G., Frljak, S., Okrajšek, R., Šebeštjen, M., Cerar, A., Andročec, V., Vrtovec, B.

Volltext

Clinical Effects of CD34+ Cell Therapy in Advanced Chronic Heart Failure Patients Listed for Heart Transplantation von Poglajen, G., Frljak, S., Zemljič, G., Okrajšek, R., Cerar, A., Šebeštjen, M., Andročec, V., Vrtovec, B.

Volltext

Long-Term Sildenafil Therapy Improves Right Ventricular Function in Heart Transplant Recipients With Pulmonary Hypertension von Vrtovec, B, Poglajen, G, Šebeštjen, M, Okrajšek, R, Frljak, S, Zemljič, G, Kšela, J, Kneževič, I, Haddad, F

Volltext

Asymptomatic Cytomegalovirus Viremia Is Associated With Increasd Risk of Pneumocystis and Fungal Infections von Poglajen, G, Podgoršek, B, Okrajšek, R, Šebeštjen, M, Frljak, S, Zemljič, G, Kšela, J, Kneževič, I, Haddad, F, Vrtovec, B

Volltext

631 Increased Red Cell Distribution Width Predicts Poor Stem Cell Mobilization in Advanced Chronic Heart Failure Patients von Poglajen, G, Okrajšek, R, Šebeštjen, M, Haddad, F, Vrtovec, B

Volltext

659 Perioperative Levosimendan Therapy Affects Short-Term Outcome after Heart Transplantation von Poglajen, G, Okrajšek, R, Šebeštjen, M, Kneževič, I, Haddad, F, Vrtovec, B

Volltext

Prognostic Significance of Early Leukopenia in Heart Transplant Recipients von Poglajen, G., Frljak, S., Zemljič, G., Cerar, A., Okrajšek, R., Šebeštjen, M., Vrtovec, B.

Volltext

Myocardial Scar Burden Correlates with NT-proBNP Levels and Changes in Left Ventricular Filling Pressures in Heart Transplant Recipients von Poglajen, G., Zbačnik, R., Frljak, S., Zemljič, G., Cerar, A., Okrajšek, R., Šebeštjen, M., Vrtovec, B.

Volltext

Prolonged Release Tacrolimus Has Comparable Safety and Efficacy Profile as Standard Release Tacrolimus in Heart Transplant Recipients von Poglajen, G., Zemljič, G., Frljak, S., Okrajšek, R., Šebeštjen, M., Cerar, A., Andročec, V., Vrtovec, B.

Volltext

Clinical Effects of CD34+ Cell Therapy in Advanced Chronic Heart Failure Patients Listed for Heart Transplantation von Poglajen, G., Frljak, S., Zemljič, G., Okrajšek, R., Cerar, A., Šebeštjen, M., Andročec, V., Vrtovec, B.

Volltext

Coronary Allograft Vasculopathy is Associated with Decreased CD34+ Cell Count in Heart Transplant Recipients von Poglajen, G., Poljančič, L., Frljak, S., Zemljič, G., Cerar, A., Okrajšek, R., Šebeštjen, M., Vrtovec, B.

Volltext

The influence of atorvastatin on walking performance in peripheral arterial disease von BREGAR, U, POREDOS, P, SABOVIC, M, JUG, B, SEBESTJEN, M

Volltext

Outcomes of COVID-19 in Heart Transplant Recipients von Poglajen, G., Frljak, S., Kokošar, B., Kotar, T., Nadrah, K., Rojko, T., Cerar, A., Zemljič, G., Okrajšek, R., Šebeštjen, M., Vrtovec, B.

Volltext

Efficacy and Safety of mRNA SARS-CoV2 Vaccination in Heart Transplant Recipients von Poglajen, G., Ihan, A., Žorž, N., Frljak, S., Petek, S., Pohar, K., Cerar, A., Zemljič, G., Okrajšek, R., Šebeštjen, M., Kneževič, I., Vrtovec, B.

Volltext

Short-Term Outcome after Heart Transplantation is Comparable When Using Extended-Criteria Donors von Poglajen, G., Zemljic, G., Frljak, S., Okrajšek, R., Šebeštjen, M., Cerar, A., Andročec, V., Jaklič, M., Vrtovec, B.

Volltext

Quantiferon-CMV Guided Virostatic Prophylaxis after Heart Transplantation von Poglajen, G., Zemljic, G., Frljak, S., Okrajšek, R., Šebeštjen, M., Cerar, A., Andročec, V., Jaklič, M., Vrtovec, B.

Volltext

(430) - Preemptive Tuberculosis Prophylaxis vs. Watchful Waiting After Heart Transplantation von Poglajen, G., Cerar, A., Frljak, S., Zemljič, G., Andročec, V., Okrajšek, R., Šebeštjen, M., Jaklič, M., Vrtovec, B.

Volltext

(831) - Safety and Efficacy of Extended Release Tacrolimus After Heart Transplantation von Poglajen, G., Frljak, S., Cerar, A., Zemljič, G., Okrajšek, R., Šebeštjen, M., Andročec, V., Jaklič, M., Vrtovec, B.

Volltext

Smoking and diabetes attenuate beneficial effects of PSCK9 inhibitors on arterial wall properties in patients with high lipoprotein (a) levels von Likozar, A. Rehberger, Sebestjen, M.

Volltext

No association between changes in lipid parameters and total PCSK9 in coronary artery disease patients treated with PCSK9 inhibitors von Ugovsek, S., Likozar, A. Rehberger, Sebestjen, M.

Volltext